Transmucosal delivery systems for calcitonin: A review

Biomaterials

Volumn 21, Issue 12, 2000, Pages 1191-1196

  Torres Lugo, Madeline ^a   Peppas, Nikolaos A ^a  

^a Purdue University   (United States)

Author keywords

Biodegradable polymers; Calcitonin; Drug delivery; Hydrogels; Non biodegradable polymers

Indexed keywords

CALCITONIN; ELCATONIN; MACROGOL; MICROSPHERE; NANOPARTICLE; POLYACRYLAMIDE; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYMER; POLYMETHACRYLIC ACID; POLYSTYRENE; SALCATONIN;

BIODEGRADATION; CONTROLLED DRUG RELEASE; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HUMAN; HYPOCALCEMIA; PRIORITY JOURNAL; REVIEW;

ACRYLIC RESINS; ADMINISTRATION, INTRANASAL; ADMINISTRATION, INTRAVAGINAL; ADMINISTRATION, ORAL; AMINO ACID SEQUENCE; ANIMALS; BIODEGRADATION, ENVIRONMENTAL; BIOLOGICAL AVAILABILITY; BIOPOLYMERS; CALCITONIN; CYANOACRYLATES; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG COMPOUNDING; FEMALE; HUMANS; HYDROGELS; LACTIC ACID; MALE; MOLECULAR SEQUENCE DATA; MUCOUS MEMBRANE; POLYETHYLENE GLYCOLS; POLYGLYCOLIC ACID; POLYMERS; POLYMETHACRYLIC ACIDS; POLYSTYRENES; SALMON; SWINE;

EID: 0034087415     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(00)00011-9     Document Type: Review

References (28)

1. Swann P.W. Recent advances in intestinal macromolecular drug delivery via receptor-mediated transport pathways. Pharm Res. 16:1998;826-834.
2. Putney S.D., Burke P.A. Improving protein therapeutics with sustained-release formulations. Nature Biotech. 16:1998;153-157.
3. Cholewinski M., Luckel B., Horn H. Degradation pathways. Analytical characterization and formulation strategies of a peptide and protein calcitonin and human growth hormone in comparison. Pharm Acta Helv. 71:1996;405-419.
4. Windich V., De Luccia F., Herman F.et al. Degradation pathways of salmon calcitonin in aqueous solution. J Pharm Sci. 86:1997;359-364.
5. Potts J.R. Chemistry of calcitonins. Bone and Mineral. 16:1992;169-173.
6. Golomb G., Avramoff A. A new route of drug administration: intrauterine delivery of insulin and calcitonin. Pharm Res. 10:1993;828-833.
7. Golomb G., Shaked I., Hoffman A. Intrauterine administration of peptide drugs for systemic effect. Adv Drug Delivery. 17:1995;179-190.
8. Richardson J.L., Ramírez A.P., Miglietta M.R.et al. Novel vaginal delivery systems for calcitonin: I. Evaluation of HYAFF/calcitonin microspheres in rats. Int J Pharm. 115:1995;9-15.
9. Richardson J.L., Ramírez A.P., Miglietta M.R.et al. Novel vaginal delivery systems for calcitonin: II. Preparation and characterization of HYAFF microspheres containing calcitonin. Int J Pharm. 144:1996;19-26.
10. Mehta R.C., Jeyanthi R., Calis S.et al. Biodegradable microspheres as depot for parenteral delivery of peptide drugs. J Control Rel. 29:1994;375-384.
11. Lee K.C., Soltis E.E., Newman P.S.et al. In vivo assessment of salmon calcitonin sustained release from biodegradable microspheres. J Control Rel. 17:1991;199-206.
12. Jeyanthi R., Thanoo B.C., Mehta R.C.et al. Effect of solvent removal technique on the matrix characteristics of poly(lactic/glycolide) microspheres for peptide delivery. J Control Rel. 38:1996;235-244.
13. Calis S., Jeyanthi R., Tsai T.et al. Adsorption of salmon calcitonin to PLGA microspheres. Pharm Res. 12:1995;1072-1076.
14. Kawashima Y., Yamamoto H., Takeuchi H.et al. Properties if a peptide containing DL-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. Eur J Pharm Biopharm. 45:1998;41-48.
15. Brunner A., Minamitake Y., Gopferich A. Labelling peptides with fluorescent probes for incorporation into degradable polymers. Eur J Pharm Biopharm. 45:1998;265-273.
16. Aydin Z., Akbuga J. Chitosan beads for the delivery of salmon calcitonin: preparation and release characteristics. Int J Pharm. 131:1996;101-103.
17. Lowe P.J., Temple C.S. Calcitonin and insulin in isobutyl cyanoacrylate nanocapsules: protection against proteases and effect on intestinal absorption in rats. J Pharm Pharmacol. 46:1994;547-552.
18. Bai J.P.F., Chang L.L., Guo J.H. Effects of poly(acrylic) polymers on the degradation of insulin and peptide drugs by chymotrypsin and trypsin. J Pharm Pharmacol. 48:1996;17-21.
19. Lueßen H.L., Verhoef C.J., Borchard G.et al. Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin. Pharm Res. 12:1995;1293-1298.
20. Baluom M., Friedman D.I., Rubinstein A. Absorption enhancement of calcitonin in the rat intestine by carbopol-containing submicron emulsions. Int J Pharm. 154:1997;235-243.
21. Serres A., Baudys M., Wankim S. Temperature and pH-sensitive polymers for human calcitonin delivery. Pharm Res. 13:1996;196-201.
22. Sakuma S., Ishida Y., Suzuki N.et al. Stabilization of salmon calcitonin by poly(styrene) nanoparticles having surface hydrophilic polymeric chains, against enzymatic degradation. Int J Pharm. 159:1997;181-189.
23. Sakuma S., Suzuki N., Kikuchi H., Hiwatari K.et al. Absorption enhancement of orally administred salmon calcitonin by poly(styrene) nanoparticles having poly(N-isopropylacrylamide) branches on their surfaces. Int J Pharm. 158:1997;69-78.
24. Sakuma S., Suzuki N., Kikuchi H.et al. Oral peptide delivery using nanoparticles composed of novel graft copolymers having hydrophobic backbone and hydrophilic branches. Int J Pharm. 149:1997;93-106.
25. Torres-Lugo M., Peppas N.A. Novel pH-sentive hydrogels for the oral delivery of calcitonin. Macromolecules. 32:1999;6646-6651.
26. Flynn, M. Oral delivery of insulin and calcitonin in humans. IBC third Annual International Conference of Delivery of Peptides and Proteins. Coronado, California, 1997.
27. New R.R.C., Kirby C.J. Solubilization of hydrophilic drugs in oily formulation. Adv Drug Delivery Rev. 25:1997;59-69.
28. Pontiroli A.E. Peptide hormones: review of current and emerging uses by nasal delivery. Adv Drug Delivery Rev. 29:1998;81-87.